A healthcare organization posted a warm, helpful list of “common questions patients ask about laparoscopic hernia treatment.” Recovery time. Pain compared with open surgery. When can I get back to work, when can I lift again, how does this change my life long-term. What the list never asks is the question 26,153 pending federal lawsuits are currently asking on behalf of other patients: should there be a piece of polypropylene mesh inside me at all?

That number is not a metaphor. As of the most recent federal multidistrict litigation counts, four manufacturers (Bard, Covidien, Atrium, Ethicon) face hernia mesh MDLs, with 26,153 cases pending across them and Bard alone carrying 23,573. Bard won the first federal bellwether trial, then lost the second and third with plaintiff verdicts, and a separate Rhode Island state-court case returned a $4.8 million verdict against the company. Bard’s parent, Becton Dickinson, announced a confidential settlement program in October 2024. Atrium settled a tranche of its cases in 2021 for a reported $66 million-plus. The FAQ does not mention any of this, because the FAQ is selling consultations, not informed consent.

When you actually ask hernia patients what they want to know, the picture shifts. A study published last month in Hernia, the field’s main journal, found that some patients scheduled for inguinal hernia repair specifically asked whether the prosthetic material could harm the body. That question was apparently common enough to make it into the paper. It is not common enough to make it onto the Reddit post.

Before I go further, I want to give laparoscopy its due, because on the comparison the FAQ is actually making, the data is on its side. A 2025 narrative review pulled the numbers cleanly. Chronic groin pain at six to twelve months: 10.3% laparoscopic versus 13.4% open, a relative risk of 0.74. Past a year, 6.6% versus 9.4%, RR 0.62. Return to work 3.4 days earlier. About 42% fewer analgesics in the first 48 hours. Patient satisfaction 88.7% versus 79.3%. If “open versus laparoscopic” were the only question on the table, the laparoscopic answer would be the honest one.

But notice what that comparison quietly assumes. Both columns involve a piece of polypropylene mesh made by companies currently writing nine-figure settlement checks. The FAQ is not lying about laparoscopy. It is letting the choice of comparison do the work, so the implant question never has to come up.

Here is what I would actually ask a hernia surgeon, sitting in the consultation, having read the litigation docket: Which specific mesh do you use, made by whom, and is its manufacturer currently in active litigation? Am I a candidate for a non-mesh repair given my age, weight, and defect anatomy? What is your personal revision rate at five and ten years, and how do you follow patients out that far? None of those are unkind. They are the questions a person who is about to receive a permanent plastic implant in their groin is fully entitled to ask before signing the consent form.

The non-mesh option does exist, and it is not fringe. The Shouldice repair has been performed since the 1940s at a hospital in Ontario built around it, and expert-center series report very low long-term recurrence, with the caveat that those results travel only as far as surgeon expertise and patient selection do. The 2023 HerniaSurge guideline update is not a blanket Shouldice endorsement (it strongly recommends mesh for the majority of adult inguinal hernias) but it explicitly keeps a non-mesh repair on the table in selected patients after shared decision-making, and when a non-mesh repair is chosen, Shouldice in trained hands is the preferred technique. A separate propensity-matched registry analysis from the Abdominal Core Health Quality Collaborative, not a randomized trial, found that open preperitoneal mesh repair beat Shouldice on patient-reported quality of life through the first year (mostly lower pain) with no difference in one-year recurrence. So mesh wins on year-one comfort in matched cohorts. The implant question is about year ten and year twenty.

The biology of why this matters is worth slowing down on, because once you see it the litigation stops looking like a freak run of bad luck. Polypropylene is a synthetic plastic. Implant any permanent foreign body and the immune system mounts a chronic, low-grade inflammatory response: macrophages move in, fibroblasts follow, and the implant gets walled off in scar tissue. That scar capsule is not inert. It contracts. As it contracts it can fold or stiffen the mesh, and the mesh sits directly on top of the genitofemoral, ilioinguinal, and iliohypogastric nerves running through the inguinal canal. Entrap one of those nerves in a sheet of contracting scarred-in plastic and you have the chronic groin pain syndrome that fills the plaintiff filings. The lighter “self-fixating” meshes were sold as the fix for that problem. Some of those products are exactly the ones now sitting in the MDLs.

So why does the Reddit post ask about recovery and lifestyle and return-to-work? Because that is what closes a consultation. “How soon can I walk the dog” gets a yes and a scheduling call. “What is the ten-year explant rate on the specific device you stock, and is its manufacturer in active litigation” gets a long pause.

I came into this assuming hernia surgery was a settled, boring corner of medicine, the kind of operation you schedule on a Tuesday and forget about. It is mostly that. It is also the place where, depending on which polymer your surgeon happens to prefer that month, you might be living with the consequences for the next forty years. The FAQ has every right to be cheerful about laparoscopy. You have every right to ask the question it left off.

Sources

  1. Drugwatch – Hernia Mesh Lawsuit: MDL case counts and settlement tracker (2026)
  2. Hernia – Do patients scheduled for inguinal hernia repair express a preference for the repair technique? (2026)
  3. PMC – The Pros and Cons of Minimally Invasive vs. Open Surgery for Inguinal Hernia Repair: A Narrative Review (2025)
  4. PMC – Who benefits from a Shouldice repair? HerniaSurge guideline context (2024)
  5. Physician’s Weekly – Open preperitoneal inguinal hernia repair has superior 1-year patient-reported outcomes compared to Shouldice non-mesh repair (2025)